SCOPUS 정보 검색 플랫폼

American Journal of Psychiatry

Volumn 167, Issue 2, 2010, Pages 216-

Antipsychotic drugs for depression?

(1) Carroll, Bernard J a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; LITHIUM; RISPERIDONE;

AKATHISIA; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG EXPOSURE; DRUG INDUSTRY; DRUG MARKETING; DYSKINESIA; HUMAN; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCIENTIFIC LITERATURE; TARDIVE DYSKINESIA;

AKATHISIA, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS;

EID: 75749120247 PISSN: 0002953X EISSN: 15357228 Source Type: Journal
DOI: 10.1176/appi.ajp.2009.09091257 Document Type: Letter

Times cited : (5)

References (4)

1
- 69949087539
- Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials
- Nelson JC, Papakostas GI: Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009; 166:980-991
- (2009) Am J Psychiatry , vol.166 , pp. 980-991
- Nelson, J.C.¹ Papakostas, G.I.²

2
- 68149125187
- STOP-PD Group: A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
- Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M; STOP-PD Group: A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the Study of Pharmacotherapy of Psychotic Depression (STOP-PD). Arch Gen Psychiatry 2009; 66:838-847
- (2009) Arch Gen Psychiatry , vol.66 , pp. 838-847
- Meyers, B.S.¹ Flint, A.J.² Rothschild, A.J.³ Mulsant, B.H.⁴ Whyte, E.M.⁵ Peasley-Miklus, C.⁶ Papademetriou, E.⁷ Leon, A.C.⁸ Heo, M.⁹

3
- 58149151374
- Examining the efficacy of adjunctive aripiprazole in major depressive disorder: A pooled analysis of 2 studies
- Thase ME, Trivedi MH, Nelson JC, Fava M, Swanink R, Tran QV, Pikalov A, Yang H, Carlson BX, Marcus RN, Berman RM: Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies. Prim Care Companion J Clin Psychiatry 2008; 10:440-447
- (2008) Prim Care Companion J Clin Psychiatry , vol.10 , pp. 440-447
- Thase, M.E.¹ Trivedi, M.H.² Nelson, J.C.³ Fava, M.⁴ Swanink, R.⁵ Tran, Q.V.⁶ Pikalov, A.⁷ Yang, H.⁸ Carlson, B.X.⁹ Marcus, R.N.¹⁰ Berman, R.M.¹¹

4
- 33750212103
- Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation
- Rapaport MH, Gharabawi GM, Canuso CM, Mahmoud RA, Keller MB, Bossie CA, Turkoz I, Lasser RA, Loescher A, Bouhours P, Dunbar F, Nemeroff CB: Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology 2006; 31:2505-2513
- (2006) Neuropsychopharmacology , vol.31 , pp. 2505-2513
- Rapaport, M.H.¹ Gharabawi, G.M.² Canuso, C.M.³ Mahmoud, R.A.⁴ Keller, M.B.⁵ Bossie, C.A.⁶ Turkoz, I.⁷ Lasser, R.A.⁸ Loescher, A.⁹ Bouhours, P.¹⁰ Dunbar, F.¹¹ Nemeroff, C.B.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.